tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

HRMY Stock Latest News

UBS starts Harmony Biosciences with Buy on Wakix growth
The FlyUBS starts Harmony Biosciences with Buy on Wakix growth
10d ago
HRMY
Harmony Biosciences initiated with a Buy at UBS
PremiumThe Fly
Harmony Biosciences initiated with a Buy at UBS
10d ago
HRMY
Harmony Biosciences management to meet with Needham
PremiumThe Fly
Harmony Biosciences management to meet with Needham
11d ago
HRMY
Harmony Biosciences reports Q2 EPS 20c, consensus (6c)
PremiumThe Fly
Harmony Biosciences reports Q2 EPS 20c, consensus (6c)
1M ago
HRMY
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
PremiumPress Releases
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
1M ago
HRMY
Needham healthcare analysts hold analyst/industry conference call
PremiumThe FlyNeedham healthcare analysts hold analyst/industry conference call
2M ago
ACAD
AVDL
Harmony Biosciences management to meet virtually with Piper Sandler
Premium
The Fly
Harmony Biosciences management to meet virtually with Piper Sandler
2M ago
HRMY
Harmony Biosciences Executive Resigns, Subsidiary Renamed
Premium
Company Announcements
Harmony Biosciences Executive Resigns, Subsidiary Renamed
3M ago
8K
HRMY
Harmony Biosciences says FDA approves sNDA for WAKIX tablets
PremiumThe Fly
Harmony Biosciences says FDA approves sNDA for WAKIX tablets
3M ago
HRMY
Harmony Biosciences initiated with a Buy at Citi
PremiumThe Fly
Harmony Biosciences initiated with a Buy at Citi
3M ago
HRMY
Harmony presents data from Phase 2 signal detection study of pitolisant
PremiumThe Fly
Harmony presents data from Phase 2 signal detection study of pitolisant
4M ago
HRMY
Harmony Biosciences Unveils Investor Presentation with Future Insights
PremiumCompany Announcements
Harmony Biosciences Unveils Investor Presentation with Future Insights
5M ago
8K
HRMY
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
PremiumPress ReleasesHarmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
5M ago
HRMY
Harmony Biosciences sees FY24 net product revenue $700M-$720M
Premium
The Fly
Harmony Biosciences sees FY24 net product revenue $700M-$720M
5M ago
HRMY
Harmony Biosciences reports Q1 adjusted EPS 88c, consensus 62c
Premium
The Fly
Harmony Biosciences reports Q1 adjusted EPS 88c, consensus 62c
5M ago
HRMY
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
PremiumPress Releases
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
5M ago
HRMY
Harmony Biosciences acquires Epygenix Therapeutics for $35M in cash
PremiumThe Fly
Harmony Biosciences acquires Epygenix Therapeutics for $35M in cash
5M ago
HRMY
Harmony Biosciences signs exclusive licensing agreement for sleeping disorders
PremiumThe Fly
Harmony Biosciences signs exclusive licensing agreement for sleeping disorders
5M ago
HRMY
Harmony Biosciences begins Phase 3 registrational study of pitolisant in PWS
PremiumThe Fly
Harmony Biosciences begins Phase 3 registrational study of pitolisant in PWS
6M ago
HRMY
Harmony Biosciences management to meet with Oppenheimer
PremiumThe FlyHarmony Biosciences management to meet with Oppenheimer
6M ago
HRMY
Harmony Biosciences management to meet with Oppenheimer
Premium
The Fly
Harmony Biosciences management to meet with Oppenheimer
6M ago
HRMY
Harmony Biosciences price target lowered to $40 from $42 at Mizuho
Premium
The Fly
Harmony Biosciences price target lowered to $40 from $42 at Mizuho
7M ago
HRMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >